FDA Recall Terminated

RANDOX CHOL-cholesterol (total) test system intended to measure cholesterol in plasma and serum REF: CH200

Recall: Z-0328-2022 · Initiated November 1, 2021

Recall

Recall Number
Z-0328-2022
Event Number
88999
Firm
Randox Laboratories Ltd. 55 Diamond Road Crumlin (North) Ireland
FEI Number
1000361607
Product Code
CHH
Status
Terminated
Root Cause
Under Investigation by firm
Initiated
November 1, 2021
Terminated
March 9, 2023

Description

RANDOX CHOL-cholesterol (total) test system intended to measure cholesterol in plasma and serum REF: CH200

Reason

When calibrating using the standard provided in the kit, the change in absorbance is lower than expected generating internal quality control results high outside range

Action

Randox USA, Distributor contacted the customer via Urgent Medical Device Correction letter email on 11/1/21. The letter states reason for recall, health risk and action to take: Action to be taken: " Discontinue use of and discard any of the above batches immediately. " Review your reagent inventory of these products and assess your laboratories needs for reimbursement for discarded inventory. " Review results generated with the affected batches in line with the clinical profile of the patient. " Discuss the contents of this notice with your Medical Director. " Complete and return the response form 12187-QA to [email protected] within five working days. Transmission of Field Safety Notice: Send a copy of the FSN to all affected customers and to those who need to be aware within your organisation. If you have any questions or concerns please contact Randox Technical Services.

Distribution

US Nationwide distribution in the states of GA, OR, PA ,WA, West Virginia.

Quantity

15 kits